IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV10I4A85

A rare cause of transient ischaemic attack in a young man: cardiac papillary fibroelastoma

Mehmet Kaya¹*, MD; Burak Ersoy¹, MD; Aydın Yıldırım², MD; Mehmet Sar³, MD; Müzeyyen İyigün4, MD; Ersin Erek¹, MD

We describe a case of cardiac papillary fibroelastoma (CPF) causing a transient ischaemic attack in a 32-year-old man. The diagnosis was established by echocardiography.

Transoesophageal echocardiography revealed a solid mass 7×8 mm in size on the primary chordae of the mitral valve (Figure 1A, Moving image 1). The tumour was resected from the primary chordae of the anterior mitral valve leaflet, including the extension beneath the chordae tissue, and was removed under cardiopulmonary bypass (Figure 1B).

Figure 1. A) Transthoracic image showing a mobile mass of the mitral valve chordae. B) Operative view of the tumour of the primary chordae of the mitral A2 scallop. C) Macroscopic view of the tumour which shows papillary projections.

The postoperative course was uneventful. Histologic examination was consistent with CPF. CPFs are usually benign and can cause neurological embolic events (Figure 1C). Thus, surgical resection should be performed regardless of the size of these tumours in both symptomatic and asymptomatic patients, because the successful complete resection of CPF is curative and the long-term postoperative prognosis is excellent. CPF should be kept in mind as a possible cause during transient ischaemic attack (TIA) in young adults.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Online data supplement

Moving image 1. Transoesophageal echocardiography reveals an isolated mass of the mitral valve chordae.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Transoesophageal echocardiography reveals an isolated mass of the mitral valve chordae.

Volume 10 Number 4
Aug 19, 2014
Volume 10 Number 4
View full issue


Key metrics

Suggested by Cory

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00832 Apr 6, 2018
Thrombosed mechanical tricuspid valve: emergent valvuloplasty as rescue
Goel K et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV12I1A20 May 16, 2016
Intracardiac thrombus trapped in a patent foramen ovale
Onur O et al
free

10.4244/EIJV11SWA7 Sep 17, 2015
Stroke prevention in valvular heart disease: from the procedure to long-term management
Giustino G and Dangas G
free

10.4244/EIJV9I4A86 Aug 23, 2013
Late aortic perforation with a fractured ATRIASEPT II device resulting in life-threatening tamponade
Hernández Pérez FJ et al
free

Viewpoint

10.4244/EIJ-D-21-00500 Oct 20, 2021
My stroke story
Noc M
free

Editorial

10.4244/EIJ-E-22-00011 Jun 3, 2022
Cerebral embolism during transcatheter mitral valve repair: not so silent after all?
Lurz P and Besler C
free
Trending articles
334.8

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
33.05

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved